優通未來(06168.HK):公司股份將自5月2日起取消上市地位
格隆匯4月21日丨優通未來(06168.HK)公佈,上市覆核委員會已於2023年3月31日就上市覆核委員會覆核進行聆訊。於2023年4月18日,上市覆核委員會通知公司上市覆核委員會決定維持退市決定。
於2023年4月20日,聯交所發出函件通知公司,股份的最後上市日期將為2023年4月28日及其股份將自2023年5月2日上午九時正起取消上市地位。
鑑於上述之股份被取消上市地位,於2023年4月20日,董事會決定取消通吿內提及追認注消股份的股東特別大會。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.